Xiaoming Hou
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Sensory Systems top 10%
Papers in
-
- Extracellular vesicles in disease 3
- Oncology 15
- HER2/EGFR in Cancer Research 3
- Colorectal Cancer Treatments and Studies 3
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Da Zhao (15 shared papers)Tao Zhang (11 shared papers)Xinan Wu (2 shared papers)Xiaojun Liu (3 shared papers)Xiaoling Ling (3 shared papers)Zhiguang Su (4 shared papers)Fei Su (8 shared papers)Xiangjin Li (1 shared paper)
- Journals
- Journal of Clinical Oncology (7 papers)Journal of Thoracic Oncology (2 papers)Frontiers in Oncology (2 papers)Frontiers in Immunology (2 papers)OncoTargets and Therapy (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Xiaoming Hou
53 papers receiving 798 citations
Peers
Comparison fields: 5 of 90
- Cancer Research 170
- Sensory Systems 30
- Oncology 156
- Molecular Biology 335
- Immunology 98
Countries citing papers authored by Xiaoming Hou
This map shows the geographic impact of Xiaoming Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoming Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoming Hou more than expected).
Fields of papers citing papers by Xiaoming Hou
This network shows the impact of papers produced by Xiaoming Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoming Hou. The network helps show where Xiaoming Hou may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoming Hou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 63 | |
| 2 | 2019 | 56 | |
| 3 | 2023 | 36 | |
| 4 | 2021 | 31 | |
| 5 | 2019 | 31 | |
| 6 | 1995 | 31 | |
| 7 | 2021 | 30 | |
| 8 | 2018 | 27 | |
| 9 | 2019 | 26 | |
| 10 | 2014 | 25 | |
| 11 | 2019 | 25 | |
| 12 | 2016 | 24 | |
| 13 | 2014 | 22 | |
| 14 | 2012 | 22 | |
| 15 | 2018 | 21 | |
| 16 | 2019 | 21 | |
| 17 | 2020 | 20 | |
| 18 | 2023 | 20 | |
| 19 | 2014 | 20 | |
| 20 | 2020 | 18 |
About Xiaoming Hou
Xiaoming Hou is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 60 papers that have together received 802 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Nanoplatforms for cancer theranostics (4 papers), interferon and immune responses (3 papers), HER2/EGFR in Cancer Research (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Extracellular vesicles in disease (3 papers). The work is most often cited by research in Cancer Research (170 citations), Sensory Systems (30 citations), Oncology (156 citations), Molecular Biology (335 citations) and Immunology (98 citations). Xiaoming Hou has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Da Zhao, Tao Zhang, Xinan Wu, Xiaojun Liu, Xiaoling Ling, Zhiguang Su, Fei Su, Xiangjin Li, Jiangying Kuang and Dongming Zhang. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Frontiers in Oncology, Frontiers in Immunology and OncoTargets and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.